Minimum Advance Royalty Payments Sample Clauses

Minimum Advance Royalty Payments. Following the Company exercising its Option rights in Clause Three to proceed with the Agreement, the concessionaire shall be entitled to receive the following schedule of Minimum Advance Royalty Payments: o Six months after the Option is exercised US$2,000 o Twelve months after the Option is exercised US$2,000 o Eighteen months after the Option is exercised US$2,500 o Twenty-four months after the Option is exercised US$2,500 o Thirty months after the Option is exercised US$3,000 o Thirty-six months after the Option is exercised US$3,000 o Forty-two months after the Option is exercised US$3,500 o Forty-eight months after the Option is exercised US$3,500 o Fifty-four months after the Options is exercised and on each six month interval, thereafter US$4,000 All Minimum Advance Royalty Payments shall be deductible by THE COMPANY against any future Production Royalty Payments due THE CONCESSIONAIRE, on an unlimited carry-forward basis.
AutoNDA by SimpleDocs
Minimum Advance Royalty Payments. On the dates described below, Romarco shall pay to Owner the sums described below: Owner’s execution of this Agreement $25,000.00 First anniversary of the Effective Date $30,000.00 Second anniversary of the Effective Date $35,000.00 Third anniversary of the Effective Date $40,000.00 Fourth anniversary of the Effective Date $45,000.00 Fifth and each subsequent anniversary $50,000.00 of the Effective Date The foregoing payments shall be minimum advance Royalty payments and shall be credited cumulatively in favor of Romarco against its obligation to pay the Royalty prescribed in Section 4.2. The foregoing cash Payments shall not be credited against the Purchase Price. Owner acknowledges that Romarco has reimbursed Owner the sum of $9,168.50 to cover the cost of filing and recording the initial 13 “DS” and 18 “GM” claims, and for the Federal annual mining claim maintenance fees for those claims for the annual assessment year September 1, 2004, to September 1, 2005. Romarco agrees to pay to Owner on execution of this Agreement the sum of $263.50 representing reimbursement of the recording fees for recording of the notice of intent to hold for the unpatented mining claims. The costs reimbursed by Romarco to Owner shall not be credited against the Purchase Price or the Royalty.
Minimum Advance Royalty Payments. Lessee shall pay Lessor the minimum advance royalty payments (hereinafter called "Minimum Payments") in the amount of Twelve Thousand Five Hundred Dollars ($12,500) per year. All Minimum Payments paid to Lessor shall be credited against any production royalties that accrue. In the event no minerals are produced from the Property, Lessor shall have no obligation to refund Minimum Payments. Lessee shall have the right to prepay any Minimum Payments. The obligation to make Minimum Payments shall terminate as of the date Lessee exercises the Purchase Option or Alternative Purchase Option as described in Section 7.
Minimum Advance Royalty Payments. Beginning on December 15, 200 1, and on the like day of each subsequent year during which Grantee holds title to the Property, Grantee shall pay to Grantor the sum of Ten Thousand Dollars ($ 10,000.00) as a minimum advance royalty payment. The minimum annual royalty payments paid by Grantee to Grantor in accordance with the parties' Mining Claim Purchase Option Agreement and this Deed shall be credited cumulatively to Grantee's account and against Grantee's Royalty obligations under this Deed.
Minimum Advance Royalty Payments. On the dates described below, Romarco shall pay to Owner the sums described below: Owner’s execution of this Agreement $ 5,000.00 First anniversary of the Effective Date $10,000.00 Second anniversary of the Effective Date $10,000.00 Third anniversary of the Effective Date $20,000.00 Fourth anniversary of the Effective Date $20,000.00 Fifth anniversary of the Effective Date $30,000.00 Sixth anniversary of the Effective Date $30,000.00 Seventh and each subsequent anniversary $40,000.00 of the Effective Date The cash Payments shall not be credited against the Purchase Price. The foregoing payments shall be minimum advance Royalty payments and shall be credited cumulatively in favor of Romarco against its obligation to pay the Royalty prescribed in Section 4.2.
Minimum Advance Royalty Payments. 4.1 Palmdale shall pay Owners minimum advance royalty payments ("Minimum Advance Royalty Payments") as follows: Upon execution of Agreement $ 50,000.00 August 11, 2012 $ 50,000.00 August 11, 2013 $ 60,000.00 All Minimum Advance Royalty Payments paid to Owners shall be credited against any Net Smelter Returns (as defined below) payable to Owners by Palmdale. In the event no Minerals are produced from the Property, Owners shall have no obligation to refund the Minimum Advance Royalty Payments. Palmdale shall have the right to prepay any Minimum Advance Royalty Payments. Palmdale shall pay the Minimum Advance Royalty Payments directly to Owners in a certified cashier’s check made out to Xxxxxxx X. Xxxxxx, Trustee, Xxxxxx Family Trust, Trust A or by electronic wire transfer. 4.2 If at any time during the Term Palmdale desires to shut down or cease production for any reason, it shall have the right to do so without terminating this Agreement by continuing to make the Minimum Advance Royalty Payments in accordance with Section 4.1. The Term of this Agreement shall remain in effect provided Minimum Advance Royalty Payments continue to be made. 4.3 In the event Palmdale fails to make the Minimum Advance Royalty Payments to Owners in the amounts and by the due dates provided for in Paragraph 4.1 such failure shall constitute a material breach of this lease and Palmdale shall have no further rights hereunder, shall immediately vacate the property, and shall lose any and all rights to exercise the option to purchase said property as provided in Section 6.

Related to Minimum Advance Royalty Payments

  • Royalty Payments (1) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate. (2) LICENSEE shall pay earned royalties quarterly on or before February 28, May 31, August 31 and November 30 of each calendar year. Each such payment shall be for earned royalties accrued within LICENSEE’s most recently completed calendar quarter. (3) Royalties earned on sales occurring or under sublicense granted pursuant to this Agreement in any country outside the United States shall not be reduced by LICENSEE for any taxes, fees, or other charges imposed by the government of such country on the payment of royalty income, except that all payments made by LICENSEE in fulfillment of UNIVERSITY’s tax liability in any particular country may be credited against earned royalties or fees due UNIVERSITY for that country. LICENSEE shall pay all bank charges resulting from the transfer of such royalty payments. (4) If at any time legal restrictions prevent the prompt remittance of part or all royalties by LICENSEE with respect to any country where a Licensed Product is sold or a sublicense is granted pursuant to this Agreement, LICENSEE shall convert the amount owed to UNIVERSITY into US currency and shall pay UNIVERSITY directly from its US sources of fund for as long as the legal restrictions apply. (5) LICENSEE shall not collect royalties from, or cause to be paid on Licensed Products sold to the account of the US Government or any agency thereof as provided for in the license to the US Government. (6) In the event that any patent or patent claim within Patent Rights is held invalid in a final decision by a patent office from which no appeal or additional patent prosecution has been or can be taken, or by a court of competent jurisdiction and last resort and from which no appeal has or can be taken, all obligation to pay royalties based solely on that patent or claim or any claim patentably indistinct therefrom shall cease as of the date of such final decision. LICENSEE shall not, however, be relieved from paying any royalties that accrued before the date of such final decision, that are based on another patent or claim not involved in such final decision, or that are based on the use of Technology.

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount: (a) with respect to sales of Product in the EU, [REDACTED] of Net Sales, [REDACTED], but in no event less than [REDACTED] of Net Sales; and (b) with respect to sales of Product in the Territory, other than in the EU: [REDACTED]; [REDACTED]; and [REDACTED]; provided, however, that in no event shall the royalty on sales of the Product in any country in the Territory (including the EU) be less than [REDACTED] per capsule sold based on a [REDACTED], [REDACTED] per capsule sold based on a [REDACTED], and [REDACTED] sold based on a [REDACTED], such amounts to be proportionately adjusted based on a scale of [REDACTED] for other capsule sizes less than [REDACTED] and based on a scale of [REDACTED] for other capsule sizes in excess of [REDACTED]; provided further, however, that if in any country in the Territory ICN is also marketing the Product, and if at any time ICN's current actual net selling price for the Product is less than [REDACTED] of Schering's current actual net selling price for the Product (based on the same capsule size and comparable terms and conditions, and other than due to increases in price by Schering), then such minimum royalty shall no longer apply to sales of the Product by Schering in such country (and such minimum royalty shall not be reinstated). In the event any third party is also marketing oral ribavirin in any country in the Territory, then Schering shall not be obligated to pay the minimum royalty provided for in this Section 6.2 for that country. [REDACTED] For purposes of this Section 6.2, the current actual net selling price shall be determined on a country-by-country basis, for each calendar quarter, by dividing the Net Sales of capsules of a particular capsule strength by the total number of capsules of the same strength that were sold and sampled in such country during such period. Each Party shall have the right to audit the books and records of the other Party for the purpose of verifying the current actual net selling price, in accordance with the procedures set forth in Section 6.10.

  • Minimum Annual Royalties Company shall pay to JHU minimum annual royalties as set forth in Exhibit A. These minimum annual royalties shall be due, without invoice from JHU, within thirty (30) days of each anniversary of the EFFECTIVE DATE beginning with the first anniversary. Running royalties and sublicense consideration accrued under Paragraphs 3.3 and 3.4, respectively, and paid to JHU during the one year period preceding an anniversary of the EFFECTIVE DATE shall be credited against the minimum annual royalties due on that anniversary date.

  • Minimum Royalties If royalties paid to Licensor do not reach the minimum royalty amounts stated in Section 3.3 of the Patent & Technology License Agreement for the specified periods, Licensee will pay Licensor on or before the Quarterly Payment Deadline for the last Contract Quarter in the stated period an additional amount equal to the difference between the stated minimum royalty amount and the actual royalties paid to Licensor.

  • Minimum Royalty At the beginning of each calendar year during the term of this Agreement, beginning January 1, 2016, Company shall pay to Medical School a minimum royalty of {***}. If the actual royalty payments to Medical School in any calendar year are less than the minimum royalty payment required for that year, Company shall have the right to pay Medical School the difference between the actual royalty payment and the minimum royalty payment in full satisfaction of its obligations under this Section, provided such minimum payment is made to Medical School within sixty (60) days after the conclusion of the calendar year. Waiver of any minimum royalty payment by Medical School shall not be construed as a waiver of any subsequent minimum royalty payment. If Company fails to make any minimum royalty payment within the sixty-day period, such failure shall constitute a material breach of its obligations under this Agreement, and Medical School shall have the right to terminate this Agreement in accordance with Section 8.3.

  • Minimum Annual Royalty Beginning in the calendar year after the first occurrence of SALEs, and in each succeeding calendar year thereafter, LICENSEE will pay to REGENTS a minimum annual royalty of [Written amount] U.S. Dollars ($ Number) for the life of this AGREEMENT. This minimum annual royalty will be paid to REGENTS by February 28 of each year and will be credited against the earned royalty due and owing for the calendar year in which the minimum payment is made.

  • Royalty Rate Licensee shall pay to Licensor three percent (3%) of the first $25 million of Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 and 4.2.3.

  • Advance Payments The Employer agrees to issue advance payments of estimated net salary for vacation periods of two (2) or more complete weeks, providing a written request for such advance payment is received from the employee at least six (6) weeks prior to the last pay before the employee’s vacation period commences, and providing the employee has been authorized to proceed on vacation leave for the period concerned. Pay in advance of going on vacation shall be made prior to departure. Any overpayment in respect of such pay advances shall be an immediate first charge against any subsequent pay entitlement and shall be recovered in full prior to any further payment of salary.

  • Minimum Amount of Each Advance Each Eurodollar Advance shall be in the minimum amount of $5,000,000 and in multiples of $1,000,000 if in excess thereof. Floating Rate Advances may be in any amount.

  • Advance Payment The right to indemnification conferred in this Article VII shall include the right to be paid or reimbursed by the Company the reasonable expenses incurred by a Person of the type entitled to be indemnified under Section 7.3 who was, is or is threatened to be made a named defendant or respondent in a Proceeding in advance of the final disposition of the Proceeding and without any determination as to the Person’s ultimate entitlement to indemnification; provided, however, that the payment of such expenses incurred by any such Person in advance of the final disposition of a Proceeding shall be made only upon delivery to the Company of a written affirmation by such Person of his or her good faith belief that he has met the standard of conduct necessary for indemnification under Article VII and a written undertaking, by or on behalf of such Person, to repay all amounts so advanced if it shall ultimately be determined that such indemnified Person is not entitled to be indemnified under this Article VII or otherwise.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!